EvokeDx is the next generation visual pathway diagnostic technology. It utilizes advanced, highly sensitive VEP and ERG techniques with powerful frequency domain analytics to objectively assess visual pathway function.
Pupillary defects are an important sign, often caused by visual pathway cell loss caused by a variety of diseases including glaucoma. Although pupil testing is required in the USA as part of the comprehensive exam, it is clinically difficult to do well and even harder to quantify objectively, until now.
Computerized visual acuity, balance, binocularity, stereopsis at distance and more in an affordable, easy to use app that can be installed on your hardware or ours. Includes an iPad interface at no charge, with novel, optional near tests starting at just $9.99